Clinical Trials Insight: 700057631

Trial Profile

Clinical Trials Insight: 700057631

Planning
Phase of Trial: Phase II

Latest Information Update: 25 Aug 2010

At a glance

  • Drugs ADX 71149 (Primary)
  • Indications Anxiety
  • Focus Therapeutic Use
  • Sponsors Addex Therapeutics
  • Most Recent Events

    • 25 Aug 2010 Now the phase I programme is complete, enrollment is expected to begin in the first quarter of 2011, according to an Addex Pharmaceuticals media release.
    • 13 Jul 2010 A phase II study of ADX 71149 is expected to start in 2010, according to an Addex Pharmaceuticals media release.
    • 13 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top